Table 1 Cytokine analysis of MSCs and CIMVs-MSCs content.

From: Immunosuppressive properties of cytochalasin B-induced membrane vesicles of mesenchymal stem cells: comparing with extracellular vesicles derived from mesenchymal stem cells

Cytokine

MSCs (pg/ml)

CIMVs-MSCs (pg/ml)

Enrichment

P value

IL-1β

60.21 ± 18.30

244.82 ± 8.13

4.1

< 0.003

IL-2

12.97 ± 1.51

25.97 ± 5.20

2.0

< 0.04

IL-3

8.30 ± 0.11

22.02 ± 2.34

2.7

< 0.007

IL-4

21.97 ± 3.19

40.10 ± 1.80

1.8

< 0.01

IL-5

4.34 ± 1.16

18.79 ± 1.57

4.3

< 0.005

IL-6

804.62 ± 127.98

3,084.32 ± 130.92

3.8

0.002

IL-9

202.76 ± 42.74

269.81 ± 18.80

1.3

< 0.09

IL-10

10.26 ± 0.26

33.10 ± 3.54

3.2

0.006

IL-12(p40)

3.20 ± 0.27

13.53 ± 0.24

4.2

< 0.0003

IL-13

100.92 ± 17.87

326.62 ± 8.09

3.2

< 0.002

IL-17

5.37 ± 0.13

12.46 ± 3.26

2.3

< 0.046

CCL11

226.23 ± 34.20

562.91 ± 57.53

2.5

< 0.01

G-CSF

10.51 ± 0.48

60.43 ± 1.78

5.7

< 0.0003

GM-CSF

52.39 ± 5.28

130.50 ± 2.19

2.5

< 0.001

CCL2

375.17 ± 37.56

2,764.96 ± 117.58

7.4

< 0.0007

CCL3

10.79 ± 2.79

50.17 ± 5.43

4.6

< 0.006

CCL4

11.12 ± 0.04

33.06 ± 2.11

3.0

< 0.0023

CCL5

5 ± 0.49

18.86 ± 1.57

3.8

< 0.0035

TNF-α

54.98 ± 12.95

314.19 ± 23.26

5.7

< 0.003